BRIDGER MANAGEMENT, LLC - Q3 2022 holdings

$330 Million is the total value of BRIDGER MANAGEMENT, LLC's 43 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 23.3% .

 Value Shares↓ Weighting
UBER BuyUBER TECHNOLOGIES INC$33,019,000
+62.5%
1,246,009
+25.4%
10.02%
+118.7%
MS  MORGAN STANLEY$27,038,000
+3.9%
342,2140.0%8.20%
+39.8%
GDDY SellGODADDY INCcl a$25,825,000
-16.7%
364,353
-18.3%
7.83%
+12.0%
CHTR  CHARTER COMMUNICATIONS INC Ncl a$20,676,000
-35.3%
68,1590.0%6.27%
-12.9%
ALC SellALCON AG$15,702,000
-28.2%
269,892
-13.8%
4.76%
-3.4%
IRTC BuyIRHYTHM TECHNOLOGIES INC$15,144,000
+17.0%
120,879
+0.9%
4.59%
+57.5%
CZR  CAESARS ENTERTAINMENT INC NE$13,283,000
-15.8%
411,7530.0%4.03%
+13.4%
TEVA  TEVA PHARMACEUTICAL INDS LTDsponsored ads$12,105,000
+7.3%
1,500,0000.0%3.67%
+44.4%
PSPCU  POST HOLDINGS PARTNERING CORunit 99/99/9999$12,050,000
-1.3%
1,250,0000.0%3.66%
+32.8%
VRTX SellVERTEX PHARMACEUTICALS INC$11,516,000
-44.1%
39,772
-45.6%
3.49%
-24.7%
HUM SellHUMANA INC$10,189,000
-37.8%
21,000
-40.0%
3.09%
-16.3%
AVANU  AVANTI ACQUISITION CORPunit 99/99/9999$10,000,0000.0%1,000,0000.0%3.03%
+34.6%
 WILLIAMS ROWLAND ACQUISITION$9,576,000
+0.8%
950,0000.0%2.90%
+35.7%
IRWD SellIRONWOOD PHARMACEUTICALS INC$9,493,000
-13.9%
916,314
-4.2%
2.88%
+15.9%
AZN SellASTRAZENECA PLCsponsored adr$8,577,000
-65.5%
156,400
-58.5%
2.60%
-53.6%
BMRN SellBIOMARIN PHARMACEUTICAL INC$8,511,000
-50.6%
100,400
-51.7%
2.58%
-33.5%
SellAIRSCULPT TECHNOLOGIES INC$8,347,000
-13.9%
1,298,141
-20.6%
2.53%
+15.9%
POST  POST HLDGS INC$8,215,000
-0.5%
100,2980.0%2.49%
+33.8%
VRSN SellVERISIGN INC$8,156,000
-48.0%
46,953
-49.9%
2.47%
-30.0%
BuyR1 RCM INC$6,945,000
+78.1%
374,800
+101.5%
2.11%
+139.7%
KRTX NewKARUNA THERAPEUTICS INC$6,433,00028,600
+100.0%
1.95%
SKIN SellTHE BEAUTY HEALTH COMPANY$5,265,000
-62.6%
446,607
-59.2%
1.60%
-49.7%
FLME  FLAME ACQUISITION CORP$4,915,000
+0.4%
500,0000.0%1.49%
+35.2%
MDU NewMDU RES GROUP INC$4,800,000175,500
+100.0%
1.46%
 DOCEBO INC$4,080,000
-5.3%
150,3000.0%1.24%
+27.5%
 BELLRING BRANDS INC$3,857,000
-17.2%
187,1220.0%1.17%
+11.4%
BPMC NewBLUEPRINT MEDICINES CORP$3,512,00053,300
+100.0%
1.06%
STAA NewSTAAR SURGICAL CO$3,283,00046,536
+100.0%
1.00%
SellRXSIGHT INC$2,661,000
-43.0%
221,732
-33.1%
0.81%
-23.3%
CNC SellCENTENE CORP DEL$2,199,000
-91.8%
28,263
-91.1%
0.67%
-89.0%
QTRX BuyQUANTERIX CORP$2,189,000
-6.5%
198,600
+37.3%
0.66%
+25.8%
ABCM  ABCAM PLCads$2,134,000
+3.7%
142,3500.0%0.65%
+39.4%
XENE SellXENON PHARMACEUTICALS INC$1,633,000
-30.7%
45,235
-41.6%
0.50%
-6.8%
PRVA BuyPRIVIA HEALTH GROUP INC$1,625,000
+25.7%
47,703
+7.4%
0.49%
+69.4%
 SURROZEN INC$1,414,000
-32.7%
700,0010.0%0.43%
-9.3%
LIVN SellLIVANOVA PLC$1,360,000
-61.0%
26,790
-52.1%
0.41%
-47.5%
MLCO NewMELCO RESORTS AND ENTMNT LTDadr$1,326,000200,000
+100.0%
0.40%
NAUT BuyNAUTILUS BIOTECHNOLOGY INC$877,000
+12.9%
413,700
+43.1%
0.27%
+52.0%
SellDERMTECH INC$826,000
-57.5%
208,600
-40.5%
0.25%
-42.7%
MSOS SellADVISORSHARES TRpure us cannabis$499,000
-77.5%
55,958
-73.9%
0.15%
-69.8%
NEXI  NEXIMMUNE INC$222,000
-65.5%
400,0000.0%0.07%
-53.8%
BuySURROZEN INC*w exp 08/01/203$129,000
+44.9%
699,999
+50.0%
0.04%
+95.0%
 WILLIAMS ROWLAND ACQUISITION*w exp 12/11/202$28,000
-30.0%
475,0000.0%0.01%
-11.1%
TECH ExitBIO-TECHNE CORP$0-1,444
-100.0%
-0.11%
VRDN ExitVIRIDIAN THERAPEUTICS INC$0-66,300
-100.0%
-0.17%
IMGN ExitIMMUNOGEN INC$0-278,000
-100.0%
-0.28%
PODD ExitINSULET CORP$0-41,000
-100.0%
-2.01%
CLVT ExitCLARIVATE PLC$0-1,641,319
-100.0%
-5.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (329591000.0 != 329634000.0)
  • The reported number of holdings is incorrect (43 != 44)

Export BRIDGER MANAGEMENT, LLC's holdings